CME vs CRBG
CME Group vs Corebridge Financial — AI-powered side-by-side comparison
VS
CRBG
Corebridge Financial
69
Buy
| Metric | CME | CRBG |
|---|
| AI Score |
63
|
69
|
| Price |
$281.06
|
$32.53
|
| P/E Ratio |
23.40×
|
18.61×
|
| ROE |
14.1%
|
-2.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
81.9%
|
86.7%
|
| Debt / Equity |
0.13×
|
1.02×
|
| Dividend Yield |
4.1%
|
3.1%
|
| RSI (14) |
68.7
|
36.6
|
| Beta |
0.267
|
1.01
|
| Expected Upside |
+3.7%
|
+0.8%
|
AI Committee View
Current Innellis committee reasoning for CME versus CRBG.
CRBG leads by 6 points.
CRBG scores 69/100 (Buy) versus CME at 63/100 (Buy).
CME Committee View
67% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.12) -- balance sheet can absorb a shock. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 15.6% shows genuine earnings power backing the valuation — Value
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
CRBG Committee View
100% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Price-to-book of 1.2x is a discount to asset value — Value
- Dividend yield of 4.4% pays you to wait — Value
- Revenue growing 33.2% YoY -- genuine top-line momentum — Growth
Bear Case
- MACD histogram negative -- bearish momentum — Technical